ArticleFrontiers in cardiovascular medicine2025
Association between acupuncture treatment exposure and mortality in patients with heart failure: a nationwide cohort study.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Patients with heart failure (HF) require continuous management, creating a need for alternative treatments to reduce mortality. In Korea, acupuncture treatment is covered by national health insurance, offering accessible care without financial burden. Hence, this study utilized claims data from the Korean National Health Insurance Service to examine the association between acupuncture exposure and mortality in patients with HF. Methods: Adults aged 20 years or older with newly diagnosed HF were included. Patients who received two or more acupuncture sessions within one year of diagnosis comprised the acupuncture treatment-exposed group (AT group), while those who received none were classified as the non-exposed group (non-AT group). Propensity score matching was used to generate a balanced 1:1 matched cohort. From one year after diagnosis, the study tracked circulatory and all-cause mortality over a five-year period, performing survival and dose-response analyses. Results: Each group included 4,315 patients, and the AT group showed significantly lower adjusted hazard ratios (aHRs) for circulatory disease-related mortality (0.79; 95% CI: 0.67-0.94) and all-cause mortality (0.73; 95% CI: 0.66-0.81). A clear dose-response relationship was observed, with greater exposure to acupuncture associated with lower aHRs. Discussion: Acupuncture within one year of HF diagnosis correlated with lower mortality from circulatory diseases and all causes. Future studies should adopt prospective and methodologically rigorous designs to validate the findings of this study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.